Venous Thromboembolism: Risk Assessment and Prophylaxis in the Medically Ill
- 27 February 2025
- book chapter
- Published by Springer Nature
- p. 1-24
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- External validation of the IMPROVE-DD risk assessment model for venous thromboembolism among inpatients with COVID-19Journal of Thrombosis and Thrombolysis, 2021
- Validation of the IMPROVE‐DD risk assessment model for venous thromboembolism among hospitalized patients with COVID‐19Research and Practice in Thrombosis and Haemostasis, 2021
- Sex differences in risk of incident venous thromboembolism in heart failure patientsClinical Research in Cardiology, 2018
- Assessment of the Relationship between Body Mass Index and Incidence of Venous Thromboembolism in Hospitalized Overweight and Obese PatientsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2017
- Idiopathic inflammatory myopathy and the risk of venous thromboembolism: a meta-analysisRheumatology International, 2017
- Extended-duration versus short-duration pharmacological thromboprophylaxis in acutely Ill hospitalized medical patients: a systematic review and meta-analysis of randomized controlled trialsJournal of Thrombosis and Thrombolysis, 2016
- Hospital Performance for Pharmacologic Venous Thromboembolism Prophylaxis and Rate of Venous ThromboembolismJAMA Internal Medicine, 2014
- Duration of venous thromboembolism risk across a continuum in medically ill hospitalized patientsJournal of Hospital Medicine, 2011
- Venous Thromboembolism in the Outpatient SettingArchives of internal medicine (1960), 2007
- Risk Factors for Venous Thromboembolism in Hospitalized Patients With Acute Medical IllnessArchives of internal medicine (1960), 2004